Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118256) titled 'Maternal Gut Dysbiosis Triggers Immune Overactivation in Preeclampsia, leading to Offspring Neurodevelopmental Disorders' on Feb. 3.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Hangzhou Women's Hospital
Condition:
Preeclampsia
Intervention:
Preeclampsia with offspring autism group:none
Recruitment Status: Recruiting
Phase: 0
Date of First Enrollment: 2026-02-03
Target Sample Size: Preeclampsia with offspring autism group:100;Normal pregnancy with normal offspring group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.ht...